Related Experiment Videos

Inhibited neoplastic phenotype by the c-Ha-ras antisense RNA

G R Lu1, C J Wu, Y Ke

  • 1Beijing Institute for Cancer Research, PRC.

Science in China. Series B, Chemistry, Life Sciences & Earth Sciences
|December 1, 1991
PubMed

Insights

This study demonstrates that antisense RNA can inhibit cancer cell growth and metastasis by targeting the c-Ha-ras oncogene. Transfection reduced tumor formation, growth speed, and lung metastasis in cancer cell lines.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Therapy

Background:

  • The c-Ha-ras oncogene plays a critical role in cell proliferation and malignant transformation.
  • Targeting oncogenes with antisense technology offers a potential strategy for cancer treatment.

Purpose of the Study:

  • To investigate the effect of antisense RNA targeting the c-Ha-ras oncogene on the malignant behavior of cancer cells.
  • To evaluate the potential of antisense RNA as a therapeutic approach for ras-oncogene-driven cancers.

Main Methods:

  • Transfection of a DNA plasmid expressing antisense RNA to the c-Ha-ras oncogene into Ha-ras transformed cell lines (GCM-3T3 and REF-4.3).
  • Assessment of malignant behaviors including growth rate, soft agar colony formation, and tumorigenicity in nude mice.
  • Quantification of lung metastasis frequency and expression levels of the ras oncogene product, p21 protein.

Main Results:

  • Transfection with antisense RNA significantly inhibited malignant behaviors in cancer cell lines.
  • Reduced growth speed, soft agar colony formation, and tumorigenicity were observed.
  • Lung metastasis frequency in GCM-3T3 cells decreased from 60% to 12.5%.
  • Expression of the ras oncogene product, p21 protein, was significantly reduced in transfected cells.

Conclusions:

  • Antisense RNA targeting the c-Ha-ras oncogene effectively inhibits neoplastic behavior and metastasis.
  • This study provides the first evidence in China of antisense RNA's inhibitory effect on neoplastic behavior.
  • Antisense RNA therapy holds promise for treating cancers driven by ras oncogene activation.

Related Concept Videos